Visit CURE at and CURE BioScience Explorations at

July 2010

National Cancer Institute Offers Funding for Small Businesses more
Events Column
Send your bioscience events to and we will post them here.
CURE's Annual Meeting and BioHaven Series
Showcase Connecticut Biopharma
From the desk of Paul Pescatello, President and CEO of CURE
During the uncertain business climate of the past two years, Connecticut bioscience has provided a measure of stability to the local economy. This important contribution was highlighted at CURE's Annual Meeting. The stories in this issue of CURE News underscore the vitality and significance of Connecticut biopharma.
For the full story
Yale Cell Biology Researcher Wins $1 Million Prize
James Rothman, a Yale cell biologist, was among eight researchers named Thursday as winners of this year’s $1 million Kavli Prizes, which honor work in astrophysics, nanoscience, and neuroscience. Rothman is one of three recipients of the neuroscience prize for his work with cell vesicles and the release of neurotransmitters, the chemical messengers that send information between neurons.
For the full story
Healthcare Reform Focus of CURE Annual Meeting
Uwe Reinhardt Explains Legislation's Impact on Biopharma;
Awards Conferred on Pfizer, Jon Soderstrom, MannKind Corporation and Boehringer Ingelheim
At the CURE 2010 Annual Meeting, the CURE Award for Excellence was presented to Pfizer for its investment in Alzheimer's research. Jon Soderstrom of Yale OCR, MannKind, and Boehringer Ingelheim also won awards.
Following the presentations, the audience heard from noted health care economist Professor Uwe Reinhardt of Yale and Princeton.
For the full story
Ion Torrent & 4 Biotechs Draw Venture Capital
Venture capital investments in the Life Sciences area in the first quarter of 2010 totaled $21.7 million, according to The MoneyTree® Report, issued quarterly by PricewaterhouseCoopers and the National Venture Capital Association, based on data from Thomson Reuters. 
For the full story
JS Genetics Presents at  CURE/Yale BioHaven Series
The company develops and markets sophisticated but highly cost-effective DNA diagnostic tests for underserved medical conditions in newborns, children, and adolescents. This focus grew out of the recognition that most genetic tests require blood samples, have longer turn-around times, and are expensive.
For the full story
Amarin Corporation Focus of CURE/Yale BioHaven Presentation
Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease. The company is headquartered in Dublin, Ireland, and has its research and development headquartered in Mystic, CT.
For the full story
Jonathan Rothberg Presents at CURE/Yale BioHaven
Dr. Rothberg is the founder of Ion Torrent Systems of Guilford, CT. The company has developed a DNA sequencing system that directly translates chemical signals into digital information on a semiconductor chip. Ion Torrent launched the Ion Personal Genome Machine in 2010. The Ion Personal Genome Machine (PGM™) sequencer can do a run in about an hour, offers semiconductor scalability and is one tenth the price of other sequencers to buy and to run, the company says.
For the full story
Connecticut Stem Cell Research Roundup
Connecticut – the stem cell state
The National Institutes of Health approved four stem cell lines developed at the UConn Stem Cell Core as eligible for use in NIH-funded research. Separately, Connecticut recently announced $9.8 million in grants to support nearly two dozen stem cell research projects by scientists at the University of Connecticut and at Yale.
For the full story
CURE Member News Digest
 454 Life Sciences helps sequence giant virus
 Achillion wins Phase 1 SBIR grant
 Alexion accelerates Japanese introduction
 Amarin ahead of schedule in triglycerides treatment trials
 Applied Spine awarded patent
 Bayer HealthCare receives orphan drug designation
 BioRelix and Dalton renew collaboration
 Boehringer Ingelheim continues worldwide growth
 Bristol-Myers Squibb authorizes stock repurchase
 CMD Bioscience awarded patent
 Connecticut Innovations gives NovaTract pre-seed support
 GlaxoSmithKline reports topline data on lupus treatment
 Hartford Hospital wins Anthem distinction
 Health Sciences International sets up as Connecticut CRO
 HistoRx gets $1.5 million from Connecticut Innovations
 MiraDx gets $1 million from Connecticut Innovations
 Ipsogen names Corinne Danan a vice president
 Johnson & Johnson SEDASYS® system wins CE Mark
 MannKind completes efficacy study re insulin product
 NanoViricides reports progress with Dengue and HIV drugs
 Pfizer and World Bank to collaborate
 Vascular Insights wins CE Mark for occlusion catheter
 UConn to renovate John Dempsey Hospital
 Yale pinpoints gene regulatory elements

For the full story
Copyright 2010 © Connecticut United for Research Excellence. All rights reserved. Visit CURE at and CURE BioScience Explorations at
Click here for Archive of back issues.
Newsletter developed and edited by HarveyMalis Communications LLC, Guilford, Conn.

Managing Your Subscriptions
Click on the "Manage your subscription" link below and then on "Edit Your Profile." To subscribe to a publication, type a "y" in the box to the right of the publication name. To unsubscribe, leave the box blank.